株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

免疫化学の世界市場

Immunochemicals

発行 Global Industry Analysts, Inc. 商品コード 240193
出版日 ページ情報 英文 281 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.88円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
免疫化学の世界市場 Immunochemicals
出版日: 2017年10月01日 ページ情報: 英文 281 Pages
概要

当レポートでは、世界の免疫化学市場について調査し、市場の動向と製品概要、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 業界概要
    • 免疫化学:概要
    • 研究抗体市場
    • 購買決定影響因子
    • 米国が世界の免疫化学市場を独占
    • 新興市場が大きな可能性
    • カタログ抗体:最大市場セグメント
    • カスタム抗体
    • プライマー抗体が市場を独占
    • 競合シナリオ
  • 市場動向と成長促進因子
    • 研究資金調達の増加が市場成長を促進
    • 中国市場が基礎研究の最大投資家に
    • 癌研究が市場を促進
    • 市場の死因トップ10における癌のリスク 他
  • 免疫化学のイントロダクション
    • 免疫化学の種類
    • 免疫化学の応用
  • 抗体:概要
    • 抗体のイントロダクション
    • 研究への応用
    • モノクローナル抗体
    • 特性
    • 応用
    • 癌治療のためのモノクローナル抗体
  • 近年の業界活動
  • 世界の市場参入企業
    • Abcam Plc.
    • Agilent Research Laboratories
    • Beckman Coulter GmbH
    • Biolegend, Inc.
    • Bio-Rad Laboratories, Inc.
    • Cell Signaling Technology, Inc.
    • GenScript Biotech Corporation
    • PerkinElmer, Inc.
    • Rockland Immunochemicals, Inc.
    • Santa Cruz Biotechnology, Inc.
    • Merck (Sigma-Aldrich Corporation)
    • Thermo Fisher Scientific Inc.
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • その他の諸国
目次
Product Code: MCP-6052

This report analyzes the worldwide markets for Immunochemicals in US$ Thousand by the following Product Types: Catalog Antibodies, and Custom Antibodies. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 116 companies including many key and niche players such as -

Abcam Plc
Agilent Research Laboratories
Beckman Coulter GmbH
Biolegend, Inc.
Bio-Rad Laboratories, Inc.
Cell Signaling Technology, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Catalog Antibodies
    • Custom Antibodies

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Immunochemicals - A Prelude
  • Research Antibodies Market: Critical Role in Drug Discovery and Research
    • Table 1: Antibody-based Application by Type: 2017 (includes corresponding Graph/Chart)
  • Key Factors Influencing Purchasing Decisions
    • Table 2: Research and Development Budget Growth of Top Pharma Companies: 2013-2018 (includes corresponding Graph/Chart)
  • Citations: One of the Key Factors Driving Research Antibodies' Purchase
  • The US Dominates the Global Immunochemicals Market
  • Emerging Markets Offer Huge Potential
  • Catalog Antibodies - The Largest Market Segment
  • Custom Antibodies: Finding Favor in Research Applications
  • Primary Antibodies Dominate the Market
  • Competitive Scenario
    • Table 3: Global Primary Research Antibodies Market by Leading Players: Market Share for the year 2016 (includes corresponding Graph/Chart)

2. MARKET TRENDS AND GROWTH DRIVERS

  • Increasing Research Funding Bolsters Market Growth
    • Table 4: NIH Budget Appropriations for Financial Years: 2007 to 2017 (includes corresponding Graph/Chart)
  • Chinese Market to Become the Largest Investor in Basic Research
  • Cancer Research Drives the Global Immunochemicals Market
    • Table 5: Growing Burden of Cancer Worldwide - Number of New Cancer Cases and Cancer-Related Deaths for the Year 2012 and 2030 (includes corresponding Graph/Chart)
  • Cancer Ranks Among the Top Ten Causes of Death Worldwide
    • Table 6: Common Cause of Cancer Deaths Worldwide - Number of Deaths due to Select Types of Cancer for 2015 (includes corresponding Graph/Chart)
    • Table 7: New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
  • 'Reproducibility Crisis' of Antibodies - A Major Cause of Concern
  • Proper Validation of Antibodies - Vendor Do their Part
  • New Technologies for Antibodies Validation
  • Personalized Medicine Offers New Growth Avenues
  • Rabbit Monoclonal Antibodies Score over Other Animal Antibodies
  • Researchers Prefer Commercial Research to Academic Research
  • Increasing Collaborations between Industry and Academia

3. AN INTRODUCTION TO IMMUNOCHEMICALS

  • Types of Immunochemicals
    • Catalog Antibodies
    • Custom Antibodies
  • Applications of Immunochemicals
    • Healthcare
    • Environmental Science
    • Crop Protection and Biotechnology

4. ANTIBODIES - A PRIMER

  • Introduction to Antibodies
  • Antibodies in Research Applications
  • Monoclonal Antibodies
  • Properties
  • Applications
  • Monoclonal Antibodies for Cancer Treatment
  • Various Types of mAbs Used in Cancer Treatment
    • Naked Monoclonal Antibodies
    • Conjugated Monoclonal Antibodies
    • Radiolabeled Antibodies
    • Chemolabeled Antibodies
    • Biospecific Monoclonal Antibodies
    • Potential Side-Effects of mAbs
  • Polyclonal Antibodies
  • Production Process
  • Properties
  • Applications
  • Conjugate Antibodies
  • Antibody Drug Conjugate Technology - An Overview
  • ADC Technology - Its Evolution and Developmental Challenges
  • Antibody Technology - Enables Better Specificity and Batch Consistency (2016)
  • ABfinity(tm) Technology
  • Linker Technology
  • Challenges
  • Pre-requisites of an Effective ADC
  • ADC Manufacturing - The Need for Outsourcing
  • Target Antigen Selection Critical in Developing Successful ADCs
  • Forms of Tumor-Related Antigens
  • Availability of ADCs
  • Antibody-Drug Conjugates (ADCs) in Development
  • ADC Market: An Insight into the Future

5. RECENT INDUSTRY ACTIVITY

  • MedImmune & Sanofi Pasteur Enters Agreement to Develop & Commercialize MEDI8897
  • TRIANNI Signs License Agreement with Fred Hutch
  • ImmunoPrecise Introduces New Research Initiative
  • Green Mountain Signs Agreement with ILRI
  • Abcam Extends License & Supply Agreement with Horizon Discovery
  • Shire Plc. Signs License Agreement with Novimmune S.A to Broaden Monoclonal Antibody Research Platform
  • Morphotek Partners with Johns Hopkins University to Research and Develop of Biological Therapies
  • Rockland Announces Availability of New Melanoma Cell Lines for Research
  • Kymab and MD Anderson Team Up for R&D in Immuno-Oncology
  • Achaogen and Crystal Bioscience to Develop Multiple Targeted Antibodies
  • Zymeworks Announces the Merger and Acquisition of Kairos Therapeutics
  • Merck Acquires Sigma-Aldrich
  • Abzena Acquires The Chemistry Research Solution LLC
  • Abcam Enters into a Definitive Agreement to Acquire AxioMx.
  • Igenica Biotherapeutics Signs Deal with MedImmune
  • Regeneron Pharma Signs Deal with The Experimental Therapeutics Institute
  • Invenra Partners with Oxford BioTherapeutics
  • Bio-Rad Labs Releases PrecisonAb(tm) Antibodies for use in Western Blotting
  • Cell Signaling Technology Releases 6 New Monoclonal Antibodies
  • Abcam Launches an Anti-PD-L1 Primary Antibody

6. FOCUS ON SELECT GLOBAL PLAYERS

  • Abcam Plc. (UK)
  • Agilent Research Laboratories (USA)
  • Beckman Coulter GmbH (USA)
  • Biolegend, Inc. (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Cell Signaling Technology, Inc. (USA)
  • GenScript Biotech Corporation
  • PerkinElmer, Inc. (USA)
  • Rockland Immunochemicals, Inc. (USA)
  • Santa Cruz Biotechnology, Inc. (USA)
  • Merck (Sigma-Aldrich Corporation) (USA)
  • Thermo Fisher Scientific Inc. (USA)

7. GLOBAL MARKET PERSPECTIVE

    • Table 8: World Recent Past, Current & Future Analysis for Immunochemicals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 9: World Historic Review for Immunochemicals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 10: World 14-Year Perspective for Immunochemicals by Geographic Region - Percentage Breakdown of Annual Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 11: World Recent Past, Current & Future Analysis for Catalog Antibodies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 12: World Historic Review for Catalog Antibodies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 13: World 14-Year Perspective for Catalog Antibodies by Geographic Region - Percentage Breakdown of Annual Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 14: World Recent Past, Current & Future Analysis for Custom Antibodies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 15: World Historic Review for Custom Antibodies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 16: World 14-Year Perspective for Custom Antibodies by Geographic Region - Percentage Breakdown of Annual Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • United States: The Largest Region for Immunochemicals Worldwide
    • Increase in NIH Funding to Support Basic Research
    • Table 17: NIH Appropriations for Financial Years: 2007 To 2017 (includes corresponding Graph/Chart)
    • Increase in Cancer Incidence Drives Oncology Research
    • Table 18: Estimated Number of New Cancer Cases in the US by Gender and Affected Site for 2017 (includes corresponding Graph/Chart)
    • Table 19: Estimated Number of Cancer-Related Deaths in the US by Gender and Body Site for 2017 (includes corresponding Graph/Chart)
    • Table 20: Estimated Number of New Cancer Cases in the US by State for 2017 (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 21: The US Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 22: The US Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 23: The US 14-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Cancer Incidence in Canada
    • Table 24: New Cancer Cases (in Thousands) in Canada by Gender for 2015 and 2016 (includes corresponding Graph/Chart)
    • Table 25: New Cancer Cases in Canada by Gender and Affected Site for 2016 (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 26: Canadian Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 27: Canadian Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 28: Canadian 14-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Table 29: Cancer Incidence and Number of Cancer-Related Deaths among Japanese Men and Women for 2015 (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 30: Japanese Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 31: Japanese Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 32: Japanese 14-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Research Funding in Europe
    • Cancer Statistics
    • Table 33: Number of New Cancer Cases in Europe (2012-2030) (in Million) (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
    • Select Key Player
  • B. Market Analytics
    • Table 34: European Recent Past, Current & Future Analysis for Immunochemicals by Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 35: European Historic Review for Immunochemicals by Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 36: European 14-Year Perspective for Immunochemicals by Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 37: European Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 38: European Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 39: European 14-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Asia-Pacific - The Fastest Growing Market for Immunochemicals Globally
    • Cancer Research: A Focal Area
  • B. Market Analytics
    • Table 40: Asia-Pacific Recent Past, Current & Future Analysis for Immunochemicals by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 41: Asia-Pacific Historic Review for Immunochemicals by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
    • Table 42: Asia-Pacific 14-Year Perspective for Immunochemicals by Region - Percentage Breakdown of Dollar Sales for China and Rest of Asia-Pacific Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
    • Table 43: Asia-Pacific Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 44: Asia-Pacific Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
    • Table 45: Asia-Pacific 14-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Dollar Sales for Catalog Antibodies and Custom Antibodies Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Increased Investments in Basic Research
    • Rising Incidence of Cancer & Age-Related Conditions: Potential Opportunity
    • Table 46: Cancer Statistics in China - New Cancer Cases and Cancer-Related Deaths for 2015
  • B. Market Analytics
    • Table 47: Chinese Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 48: Chinese Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 49: Chinese 14-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5b. REST OF ASIA-PACIFIC

  • Market Analysis
    • Table 50: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 Through 2024 (includes corresponding Graph/Chart)
    • Table 51: Rest of Asia-Pacific Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
    • Table 52: Rest of Asia-Pacific 14-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 53: Latin American Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 54: Latin American Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 Through 2015 (includes corresponding Graph/Chart)
    • Table 55: Latin American 14-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 56: Rest of World Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 57: Rest of World Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 58: Rest of World 14-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top